Cargando…
Use of NSAIDs via the Rectal Route for the Prevention of Pancreatitis after ERCP in All-Risk Patients: An Updated Meta-Analysis
The aim of this study was to assess the efficacy of the rectal administration of nonsteroidal anti-inflammatory drugs (NSAIDs) in preventing post-ERCP pancreatitis (PEP). We searched database for randomized controlled trials (RCTs) comparing periprocedural rectal administration of NSAIDs with placeb...
Autores principales: | Yu, Lei-Min, Zhao, Ke-Jia, Lu, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822867/ https://www.ncbi.nlm.nih.gov/pubmed/29576766 http://dx.doi.org/10.1155/2018/1027530 |
Ejemplares similares
-
Prevention of post-ERCP pancreatitis: NSAID or pancreatic stent or both?
por: van Wanrooij, R. L. J., et al.
Publicado: (2019) -
How and When Should NSAIDs Be Used for Preventing Post-ERCP Pancreatitis? A Systematic Review and Meta-Analysis
por: Puig, Ignasi, et al.
Publicado: (2014) -
Prophylactic Effect of Somatostatin in Preventing Post-ERCP Pancreatitis: An Updated Meta-Analysis
por: Qin, Xie, et al.
Publicado: (2015) -
Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis
por: Nawaz, Muhammad Haseeb, et al.
Publicado: (2020) -
Underutilization of prophylactic rectal indomethacin and pancreatic duct stent for prevention of post-ERCP Pancreatitis
por: Issak, Abdulfatah, et al.
Publicado: (2021)